Skip to content

Clinical trials

Atherosclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: United States Clear all

461 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200110
20026
200314
200418
200515
200621
200724
200822
200931
201020
201120
201217
201311
201416
201512
201617
201725
201814
201915
202011
202115
202212
202312
202417
202518
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed327
Recruiting39
Terminated35
Active, not recruiting25
Unknown status19
Withdrawn11
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)39
GlaxoSmithKline19
Massachusetts General Hospital19
Boston Scientific Corporation11
Novartis Pharmaceuticals10
Brigham and Women's Hospital9
Emory University8
Johns Hopkins University8
VA Office of Research and Development8
Abbott Medical Devices7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis461
Cardiovascular Diseases114
Coronary Artery Disease88
Inflammation39
Peripheral Arterial Disease35
Coronary Disease33
Heart Diseases32
Hypercholesterolemia32
Hypertension31
Diabetes Mellitus30

Trials

Showing 1 to 25 of 461. Each trial links to its page on Pharma Observatory.

361 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.